Respiratory Flashcards

(96 cards)

1
Q

ECG changes in PH

A

RAD
Tall P in II
Tall R in V1
poor R wave progression
Inferior TWI
RBBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Asbestos Related Pleuropulmonary Disease

A
  1. Asbestosis
  2. Pleural disease
    a. Benign asbestos effusion
    b. Focal and diffuse benign pleural plaques
  3. Malignancies
    a. NSCLC
    b. Small cell carcinoma
    c. Mesothelioma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Asbestos Related Malignancy

A

Asbestos exposure RR of lung cancer of 3.5

  • Compared with non-smokers without asbestos exposure,
  • OR 1.70 (95% CI 1.31–2.21) among asbestos-exposed non-smokers,
  • OR 5.65 (95% CI 3.38–9.42) among smokers without asbestos exposure,
  • OR 8.70 (95% CI 5.8–13.10) among asbestos-exposed smokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic beryllium disease

Clinical featurs and CT findings

A

Beryllium is used in metal and alloy machine shops, electronics, ceramics, aerospace industries
Clincal features:
- cough and SOB (common)
- fever, night sweats, fatigue

HRCT findings:
- nodules in varying sizes
- thickened septal lines
- ground glass opacities
- cystic cavitation
- bronchial wall thickening
- adenopathy involving the hiulum or mediastinum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ABPA diagnostic criteria

A
  1. Asthma or CF
  2. need both: a) positive skin prick test or increased IgE levels to A. fumigatus b) Elevated IgE conc (>1000 IU)
  3. 2/3 of following:
    a. Positive Aspergillus precipitants or IgG to A. fumigatus
    b. Radiology consistent with ABPA
    c. Total Eosinophil count >0.5 x 10^6 ub steroid naive pt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ABPA radiology findings

A
  • Proximal cylindrical bronchiectasis
  • Mucus plugging
  • Tree in bud opacity
  • Atelectasis
  • Peripheral consolidation
  • Ground glass opacity
  • Mosaic attenuation with gas trapping
  • CT is normal in ~20%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Positive prognostic factors for Sarcoid

A

<40years
Asymptomatic LN on chest imaging
Acute inflammatory manifestation
Lack of evidence of organ failure or progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Negativeprognostic factors for Sarcoid

A
  • Age>40
  • Pulm fibrosis on CT
  • Lung function impairment
  • Pulm. HTN
  • Extrapulmonary involvement
  • Lupus pernio
  • Chronic hypercalcaemia
  • Cystic bone lesions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CF mutation types:

A

Type 1: no functional CFTR
Type 2: F508del defect trafficking - most common
Type 3: G551D defect channel opening
Type 4: defect in conduction
Type 5: low quantity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Microscopic changes in lung with ageing

recoil, collagen, aveoli, compliance

A

Old:
reduced recoil
increased compliance
reduced aveoli volume
reduced collagen1 and increased collagen 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Factors associated with an increased incidence of HAPE

A

Male
cold ambient temperatures
preexisting respiratory infection
vigorous exertion

Preexisting conditions or anatomic abnormalities that lead to increased pulmonary blood flow, pulmonary hypertension, or increased pulmonary vascular reactivity may predispose to HAPE, even at altitudes below 2500 m. These include:
1. primary pulmonary hypertension
2. congenital absence of one pulmonary artery
3. left-to-right intracardiac shunts, such as atrial septal defects and ventricular septal defects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe Haemophilus influenzae on a gram stain

A

Gram -ve bacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe Moraxella catarrhalis on a gram stain

A

Gram negative diplicoccus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which lung nodule does not need FU?

A

solid nodules 6 mm or less in diameter in low-risk adults >35 years old generally need no further follow-up.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Low glucose in pleural fluid?

A

Malignancy
TB
SLE
Oesophageal rupture
RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mechanism of isoniazid resistance in TB?

A

Isoniazid acts by inhibiting the synthesis of mycolic acids through the NADH-dependent enoyl-acyl carrier protein (ACP)-reductase. This drug requires the activity of mycobacterium catalase peroxidase to be activated, therefore mutations in the enzyme lead to drug resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What causes rifampicin resistance in TB?

A

Mutation in RNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the RAPID score?

A

looks at the individual factors in infected pleural effusion that confers an adverse prognosis
- Advanced age
- absence of purulent fluid
- low albumin
- increased serum urea
- presence of hospital acquired infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Mycophenolate is not used routinely as studies have shown inferiority compared to AZA- which condition?

A

GPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Direct vs indirect provocation tests

A

Direct: methacholine, histamine
- sensitive, not specific
- use bronchodilators

Indirect: hypertonic saline, mannitol, adenosine
- specific for inflammation, thus asthma
- use ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

COPD triple therapy

LAMA/LABA/ICS

A

reduced mod-severe exacerbation
reduced hospitalisation
better lung function

BUT, increased pneumonia (even cf LABA/ICS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

CI for spirometry

A
  • High: recent MI, PE, AAA, pneuomothorax
    Acute illness (relative)
    SBP >200 or DBP >120
  • Mod: major thoracic, abdominal, head surgery
  • Less serious surgical procedures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

RF for group 1 PAH

A

CTD: SSc, Raynaud’s SLE, MCTD, RA
HIV
Portal HTN
CHD: septal defect, Eisenmenger syndrome
Schistosomiasis (most common worldwide)

Drugs:
- Dasatinib
- Toxic rapeseed oil
- Methampetamines

Possible:
- Leflunamide
- Alkylating agents
- IF alpha/beta
- Amphetamines
- St John’s wort
- L-tryptophan
- Cocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

BMPR2 mutation

A
  • accounts for 70-80% of familial PAH (type1)
    but only 25% with BMPR2 mutation develop PAH
  • Tend to present early, more severe dx, increased risk of death

AD with incomplete penetrance

Other genes: ALK1, ACVRL1, 5HTT, ENG, SMAD9, KCNK3, CAV 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
RF for CTEPH
pro-coagulant state Lupus anticoagulant APS Splectomy indwelling IV line Permenant IV devices **IBD** **PCRV and ET** Malignancy **High dose thyroid replacement **
26
PVOD
27
What is selxipag?
28
Primary ciliary dyskinesia
Agenesis of frontal sinues absent dynein arm Abnormal real time electron microscopy study of nasal biopsy
29
Narcolepsy and HLA
HLA DR2
30
Can PJP be culutred?
Pneumocystis cannot be cultured, the diagnosis relies upon the visualization of the cystic or trophic forms in appropriate specimens. Stains that have commonly been used selectively stain the cell wall of the cystic form, and include **Gomori-methenamine silver **
31
What's the first line treatement of cataplexy?
Venlafaxine
32
Treatment of narcolepsy without cataplexy?
Modafinil is first line for the somnolence associated with narcolepsy
33
Pregnancy and lung function?
1. The forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC ratio, and peak expiratory flow **do not change** significantly during normal pregnancy. 2. Residual volume** (RV) **and functional residual capacity** (FRC)** **decrease during pregnancy**, while total lung capacity (TLC) decreases only slightly in the last trimester 3. **Minute ventilation increases** during pregnancy, associated with **increased tidal volume**, presumably due to increased circulating levels of progesterone. Thus, normal pregnancy is associated with a **compensated respiratory alkalosis. **
34
Change in sleep with age:
- total sleep time decreases - sleep onset or latency becomes delayed - there is an increase in daytime napping - increase in awakenings and arousals - decreased sleep efficiency **- increased stage 1 and 2 sleep - decreased stage 3 and 4 (slow wave sleep) - decrease in REM sleep ** - there is fewer sleep cycles at night. The circadian phase is also typically advanced (ie early to bed and early to rise)
35
VTE risk with pregnancy
The risk of VTE is increased equally across all three trimesters, however the risk is highest post partum (with VTE risk increasing 4x)
36
HAPE
37
HACE
38
LENT score | when do you use it? what's in it?
39
Riociguat
Stimulator of soluble guanylate cyclase indicated for the management of persistent or recurrent **chronic thromboembolic pulmonary hypertension** and **pulmonary arterial hypertension.**
40
CI to lung cancer surgery
SVC obstruction, FEV < 1.5, MALIGNANT pleural effusion, and vocal cord paralysis
41
What are typical CT findings for UIP?
Honey combing Traction bronchiectasis Lower lobe and peripheral predominance No atypical features
42
Features that suggest UIP is unlikely
Subpleural sparing Peribrochovascular predominance Groundglass separate from honeycombing Mosaic attenuation Cysts Diffuse nodules Consolidation
43
RF for IPF
Age 50-70 Male past smoking history no alternative cause
44
Tell me about PALM
It's sporadic cystic lung disease associated with tuberous sclerosis complex on CT you can see DIFFUSE bilateral cystic disease FEMALES only Associated with angiomyolipomas in the kidneys and meningiomas complications: chylothorax, pneumothorax Tx: - Lung transplant - Sirolimus
45
LIP
46
LCHC
47
What causes plateuing of inspiratory loop but not expiratory (variable extrathoracic obstruction):
Vocal cord paralysis - unilateral
48
In a flow vol loop
Normal inspiration: variable intrathoracic problem - trachiomalacia Normal expirtion: variable extrathoracic problem Both affected: fixed
49
Low DLCO, but high KCO
think loss of lung: - prev. lobectomy - severe pleural disease - Kyphoscoliosis - Diaphragmantic paralysis
50
Increased DLCO
SAMPLE: - severe obesity - asthma - Mild LVF - POlycythaemia - Pulm. haemorrhage - L->R intracardiac shunt - Exercise
51
which drug to avoid in narcolepsy
Prazosin
52
serum neuron specific enolase: which cancer is it associated with
SCLC
53
Hounsfield units; when is it used
Nodules - >164 is likely to be benign
54
poor prognostic factors in CF
Low FEV1, High CO2, High WCC, Female
55
Elexacaftor/Ivacaftor/Tezacaftor - are beneficial in which phenotype?
Phe508del - gating or residual function
56
What is the most common symptom in bronchiectasis>
productive cough
57
CT features of bronchiectasis:
Bronchoarterial ratio>1 Lack of airway tapering Airway visibility within 1cm of the costal pleural margin Touching the mediastinal pleura Indirect signs: -bronchial wall thickening -Mucus impaction -Mosaic perfusion/air trapping on exp. CT
58
What is a signet ring sign on CT-chest?
Associated with bronchiectasis - where the bronchi is much larger than the associated blood vessel
59
Common causes of bronchiectasis:
- Idiopathic (40%) - Post infectious (30%) - Immunodef - COPD - CTD - ABPA - PCD - Asthma - NT mycobacteria
60
Lung function and primary immunodeficiency?
Primary immunodeficiency is associated with worseing lung fucntion - esp XLA High dose IVIG has shown to be helpful in reducing the rate of decline
61
Bronchiectasis overlap sx | BE-RA BE-COPD
worse outcome
62
Bronchiectasis severity score
Age, BMI, FEV1 Hospital admission, # of exacerbation MRC score P.aeruginosa Other organism CT severity
63
Which Ig def is associated with increased exacerbation in BE?
IgG2
64
Macrolide for exacerbation prevention | Azithromycin
- Both immunomodulatory effect and antibacterial effect - Azithromycin 500mg 3 x week showed reduction in frequency of exacerbation - But, no difference in: - FEV1, QoL (but longterm macrolide use improved QoL), colonisation, sx - greater benefit in pseudomonas colonisers
65
The effect of pseudomonas in BE
- worse mortality and morbidity
66
CF diagnostic criteria
1. 1 or more: -classic phenotype - sibling with CF - positive newborn screen 2.>1: - abnormal sweat test on 2 or more occasions - 2 CFTR variants identified - abnormal nasal potential differential testing
67
What's the chloride level on sweat test signficant for CF?
>60 = highly likely <29 = unlikely
68
What are the 2 most common clinical manifestation of CF?
Sinusitis MAle infertility
69
Pseudomonas and CF?
70% of CF adults are chronically colonised Mucoid phenotype is associated with worse lung fucntion
70
Azithromycin in CF
- Improves FEV1 - Reduced exacerbation - -antibacterial effcet against pseudomonas - anti inflammatory effect - reduces biofilm production ## Footnote DO NOT USED in NT mycobacterium colonised pt as increased risk of resistance
71
Airway secretion management in CF?
inhaled Dornase alpha: - reduced exac - improved FEV1 - improves QoL inhaled hypertonic saline - reduces exac PEP: - reduces exac
72
Most frequent pathogen in CF
- Staph aereus ealier in life - then pseudomonas after 35 Haemophilus is higher in early life subsides after teenage
73
Burkholderia cepacia complex in CF
* Chronic infection results in **accelerated decline **in lung function and **shortened survival** * Usually, multi-drug resistant *** Worse outcomes with lung transplantation** esp with B. cenocepacia * Infection control measures to prevent cross infection between CF patients
74
*Non-tuberculous mycobacteria in CF: 10-20%
MAC is not assocaited with worse transplant outcome M. abscessus IS associated with worse lung fucntion and transplant outcome
75
Ivacaftor and G551D mutation
G551D mutation is assocaited with Type 3 CF - defect in channel opening - Ivacaftor has shown to improve FEV1, reduced exac risk, reduce hospitalisation - resutls in weight gain (which is good for CF pts)
76
Lumacaftor and Ivacaftor in DeltaF508
Detla F508 is the most common mutation in CF Type 2 CF - problem with misfolding od protein and trafficking to mb Lumacaftor partially corrects the misfolding and Ivacaftor helps with channel opening Small improvement in FEV1, QoL and BMI Reduced exac risk but ~15% don't tolerate it ## Footnote In heterozygote the only improvement was int he sx score and sweat chloride level
77
Tezacaftor/Ivacaftor data
In F508 homozygotes: - improved QoL, exac, FEV1 but not change BMI in F508 hetero: - the combo showed improvedment in FEV1 and QoL - cf. ivacaftor monotherapy and placebo
78
Elexacaftor/Teza/Ivacaftor
in delta F508: Heterozygotes: improved cl transport to ~50% of normal Improved FEV1 and reduced exac Homozygotes: improved it to >50% improved QoL In homozygotes: Triple therapy cf Teza/Iva: improved FEV1 by 10% and QoL ## Footnote Triple therapy in F508 mutation: - improved FEV1 by ~15% - Weight gain - reduced LTOT, noctural NIV need, PEG feeding, transplant
79
Positional OSA is more prevalent in young and non-obese pts
REM OSA is more common in female and is associated with HTN, CVD, neurocognitive sx, insulin resistance
80
OSA with COPD --> increased risk of death and exacerbations
In HF, OSA or CSA increases mortality risk ## Footnote In diabetes, CPAP improves glycaemic control
81
OSA is common in non-dialysis CKD
OSA and hypoxia may predispose to NASH in severe obesity
82
Increasing OSA severity is associated with increased risk of HTN
83
Benefit of wt loss in OSA
10% weight loss --> 25% improvement in OSA
84
Does CPAP have an effect on HbA1c
no
85
Proven benefit of CPAP
Reduced AHI Improves symptoms Reduced MVA Improves erectile dysfunction Improves QoL Improves insulin resistance in non-diabetics with OSA ## Footnote Potential improvement in HTN; more beneficial in more severe OSA with high baseline BP or resistant HTN
86
OSA and CVD evidence
1. reduced risk of revascularisation after PTCA in CPAP treated OSA pt 2. CPAP modestly lowers BP by 2-4mmHg in pts with mod-severe OSA 3. CPAP did not reduce cardiovascular events in secondary prevention trial in mod-severe OSA ## Footnote 1. Retrospective study 3. There was an observational study that showed benefit with CPAP
87
Oral appliances and OSA
reduces AHI useful in all severity but less responsive cf. CPAP in mod-severe OSA reduction in AHI with CPAP is greater, but OA has a better compliance improves QoL
88
Risk factors for CSA and CSR in HF
Male, >60 AF, low LVEF, daytime hypocapnia PaCO2<38
89
RLS is associated with ## Footnote Willis-Ekbom sx
**iron deficiency** Coeliac ADHD COPD Depression/Panic Fribromyalgia PD MS Migraines Drugs: Dopamine antagonist SSRIs Neuroleptics Lithium Beta blockers
90
Diagnostic criteria for narcolepsy
MSLT<8mins or sleep latency (on PSG) <10min, REM sleep latency <20min AND: >2 sleep onset REM ## Footnote REM within 15mins on PSG is suggestive of narcolepsy
91
REM behavioural disorder
-associated with synucleinopathies (LBD, PD, MSA) - very common with PD *parkinsonism improves during RBD* - can predate dementia by 10years - **lack of REM atonia** on PSG Tx: - clonazepam - melatonin
92
Somnambulism | Sleep walking
peak incidence 11-12 years Associated with HLA DQB1 commonly arises in **nREM** RF: sleep dep, emotional distress, febrile illness, physical activity
93
Klein-Levin syndrome
Periodic hypersomnia
94
HLA association to narcolepsy
HLA DQB1*0602 *DR3*
95
What type of hypersensitivity reaction does ABPA illustrate?
Type 1,3, 4b
96
Which ILD resolves with smoking cessation?
RBILD and DIP